• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的每日一次、优化的、固定剂量组合的1.2%磷酸克林霉素和2.5%低浓度过氧化苯甲酰凝胶,用于治疗中度至重度痤疮。

A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne.

作者信息

Gold Michael H

机构信息

Gold Skin Care Center and Tennessee Clinical Research Center, Nashville, Tennessee.

出版信息

J Clin Aesthet Dermatol. 2009 May;2(5):44-8.

PMID:20729964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2924134/
Abstract

The treatment of acne with combination therapy is commonplace with treatment aimed at sustained efficacy with minimal side effects, maximum adherence, and the avoidance of bacterial resistance. Combinations containing clindamycin and benzoyl peroxide have been shown to be effective, but the irritation caused by the concentration of benzoyl peroxide 5% in the more commonly used, fixed combinations can be limiting. In addition, surfactants, preservatives, and high levels of organic solvents, including alcohols, often used in combination with benzoyl peroxide, are potential irritants. An optimized formulation of clindamycin and benzoyl peroxide using a lower concentration of benzoyl peroxide (clindamycin-benzoyl peroxide 2.5% gel) has been developed without the use of surfactants or alcohol. It was recently introduced for the once-daily treatment of inflammatory and noninflammatory lesions in moderate-to-severe acne. Following a clinical program that studied more than 2,800 patients, clindamycin-benzoyl peroxide 2.5% was found to be highly effective and well tolerated. This review highlights the development of clindamycin-benzoyl peroxide 2.5% gel and the data from clinical trials.(J Clin Aesthetic Dermatol. 2009;2(5):44-48.).

摘要

痤疮联合治疗很常见,其治疗目标是疗效持久、副作用最小、依从性最高且避免细菌耐药。含克林霉素和过氧化苯甲酰的联合用药已被证明有效,但在更常用的固定组合中,5%浓度的过氧化苯甲酰所引起的刺激可能会有局限性。此外,通常与过氧化苯甲酰联合使用的表面活性剂、防腐剂以及高浓度有机溶剂(包括酒精)都是潜在的刺激物。已研发出一种优化配方的克林霉素和过氧化苯甲酰制剂,使用较低浓度的过氧化苯甲酰(克林霉素 - 过氧化苯甲酰2.5%凝胶),且未使用表面活性剂或酒精。它最近被用于中重度痤疮炎性和非炎性皮损的每日一次治疗。在一项对2800多名患者进行研究的临床项目之后,发现克林霉素 - 过氧化苯甲酰2.5%凝胶疗效显著且耐受性良好。本综述重点介绍了克林霉素 - 过氧化苯甲酰2.5%凝胶的研发情况以及临床试验数据。(《临床美容皮肤病学杂志》。2009年;2(5):44 - 48。)

相似文献

1
A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne.一种新型的每日一次、优化的、固定剂量组合的1.2%磷酸克林霉素和2.5%低浓度过氧化苯甲酰凝胶,用于治疗中度至重度痤疮。
J Clin Aesthet Dermatol. 2009 May;2(5):44-8.
2
Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-severe Acne: An Update.1.2%克林霉素磷酸酯和2.5%过氧化苯甲酰凝胶治疗中度至重度痤疮:最新进展
J Clin Aesthet Dermatol. 2012 Jan;5(1):30-5.
3
Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.一项关于1.2%克林霉素磷酸酯与3.75%过氧化苯甲酰凝胶固定组合治疗中度至重度寻常痤疮试验的亚组分析。
J Clin Aesthet Dermatol. 2015 Dec;8(12):22-6.
4
Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.克林霉素/过氧化苯甲酰凝胶:痤疮治疗应用综述
Am J Clin Dermatol. 2002;3(5):349-60. doi: 10.2165/00128071-200203050-00007.
5
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.克林霉素/过氧化苯甲酰凝胶(BenzaClin):痤疮治疗应用综述
Am J Clin Dermatol. 2008;9(3):193-204. doi: 10.2165/00128071-200809030-00010.
6
Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris.1.2%磷酸克林霉素/3.75%过氧化苯甲酰水凝胶治疗寻常痤疮的概况
Clin Cosmet Investig Dermatol. 2015 Oct 29;8:549-54. doi: 10.2147/CCID.S79628. eCollection 2015.
7
Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris.磷酸克林霉素(1.2%)和过氧化苯甲酰(3.75%)水凝胶固定组合治疗中度或重度寻常型青少年痤疮的疗效和耐受性
J Clin Aesthet Dermatol. 2015 May;8(5):28-32.
8
Management of comedonal acne vulgaris with fixed-combination topical therapy.采用固定复方局部治疗法治疗寻常性粉刺痤疮
J Cosmet Dermatol. 2018 Apr;17(2):227-231. doi: 10.1111/jocd.12497. Epub 2018 Jan 30.
9
Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.克林霉素/过氧化苯甲酰凝胶联合治疗痤疮与克林霉素凝胶、过氧化苯甲酰凝胶及赋形剂凝胶的比较:两项双盲研究的综合结果
J Am Acad Dermatol. 1997 Oct;37(4):590-5. doi: 10.1016/s0190-9622(97)70177-4.
10
Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.一种新型过氧化苯甲酰/克林霉素外用凝胶治疗寻常痤疮的研究。
Cutis. 2001 Feb;67(2 Suppl):13-20.

引用本文的文献

1
Identifying and appraising patient-reported outcome measures on treatment satisfaction in acne: a systematic review.识别和评价痤疮治疗满意度的患者报告结局测量指标:系统评价。
Br J Dermatol. 2021 Jul;185(1):36-51. doi: 10.1111/bjd.19675. Epub 2020 Dec 28.
2
Niosomal Benzoyl Peroxide and Clindamycin Lotion Versus Niosomal Clindamycin Lotion in Treatment of Acne Vulgaris: A Randomized Clinical Trial.纳米脂质体过氧化苯甲酰与克林霉素洗剂对比纳米脂质体克林霉素洗剂治疗寻常痤疮的随机临床试验
Adv Pharm Bull. 2019 Oct;9(4):578-583. doi: 10.15171/apb.2019.066. Epub 2019 Oct 24.
3
Laser and Light-Based Treatment Modalities for the Management of Hidradenitis Suppurativa.激光和基于光的治疗方式在治疗化脓性汗腺炎中的应用。
Am J Clin Dermatol. 2020 Apr;21(2):237-243. doi: 10.1007/s40257-019-00491-1.
4
Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.新型固定剂量复方0.3%阿达帕林/2.5%过氧化苯甲酰凝胶单药疗法有效治疗中度和重度寻常炎性痤疮:一项随机、双盲、平行组对照研究
Am J Clin Dermatol. 2016 Jun;17(3):293-303. doi: 10.1007/s40257-016-0178-4.
5
Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris.1.2%磷酸克林霉素/3.75%过氧化苯甲酰水凝胶治疗寻常痤疮的概况
Clin Cosmet Investig Dermatol. 2015 Oct 29;8:549-54. doi: 10.2147/CCID.S79628. eCollection 2015.
6
Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-severe Acne: An Update.1.2%克林霉素磷酸酯和2.5%过氧化苯甲酰凝胶治疗中度至重度痤疮:最新进展
J Clin Aesthet Dermatol. 2012 Jan;5(1):30-5.

本文引用的文献

1
The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.克林霉素与过氧化苯甲酰水凝胶固定组合的研制与优化
J Drugs Dermatol. 2009 Jul;8(7):634-8.
2
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.一种含1.2%磷酸克林霉素和2.5%过氧化苯甲酰的水性凝胶固定复方制剂,用于寻常痤疮中重度患者的每日一次治疗:2813例患者的疗效和安全性评估
J Am Acad Dermatol. 2008 Nov;59(5):792-800. doi: 10.1016/j.jaad.2008.06.040. Epub 2008 Sep 20.
3
Practical considerations in acne treatment and the clinical impact of topical combination therapy.痤疮治疗中的实际考量及局部联合治疗的临床影响
Pediatr Dermatol. 2008 Jun;25 Suppl 1:1-14. doi: 10.1111/j.1525-1470.2008.00667.x.
4
Pediatric acne: clinical presentations, evaluation, and management.儿童痤疮:临床表现、评估与管理
J Drugs Dermatol. 2007 Jun;6(6):589-93.
5
Acne vulgaris--psychosomatic aspects.寻常痤疮——身心方面
J Dtsch Dermatol Ges. 2006 Dec;4(12):1027-36. doi: 10.1111/j.1610-0387.2006.06110.x.
6
'Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man.过氧化苯甲酰和维甲酸的“角质剥脱”特性在人体中与水杨酸相似。
Skin Pharmacol Physiol. 2006;19(5):283-9. doi: 10.1159/000093984. Epub 2006 Jun 16.
7
To follow or not to follow dermatological treatment--a review of the literature.是否遵循皮肤科治疗——文献综述
Acta Derm Venereol. 2006;86(3):193-7. doi: 10.2340/00015555-0073.
8
Impact of once- and twice-daily dosing regimens on adherence and overall safety.每日一次和每日两次给药方案对依从性和总体安全性的影响。
AIDS Read. 2004 Jun;14(6):320-2, 324, 329-31, 334-6.
9
The impact of reducing dose frequency on health outcomes.降低给药频率对健康结果的影响。
Clin Ther. 2003 Aug;25(8):2307-35; discussion 2306. doi: 10.1016/s0149-2918(03)80222-9.
10
Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.痤疮的管理:来自全球改善痤疮治疗结果联盟的一份报告。
J Am Acad Dermatol. 2003 Jul;49(1 Suppl):S1-37. doi: 10.1067/mjd.2003.618.